Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss (original) (raw)

Blyth, K. ORCID logoORCID: https://orcid.org/0000-0002-9304-439X, Terry, A., O'Hara, M., Baxter, E.W., Campbell, M., Stewart, M., Donehower, L.A., Onions, D.E., Neil, J.C. ORCID logoORCID: https://orcid.org/0000-0003-4447-8279 and Cameron, E.R. ORCID logoORCID: https://orcid.org/0000-0001-8311-1491(1995) Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.Oncogene, 10(9), pp. 1717-1723. (PMID:7753548)

Full text not currently available from Enlighten.

Abstract

Activation of the c-myc oncogene and functional loss of the p53 tumour suppressor gene are among the most frequently recorded genetic lesions in neoplasia but their combined effect has not previously been investigated. By breeding together mice transgenic for human c-myc (CD2-myc) and mice carrying an inactive p53 allele (p53-/-) we found that these genetic lesions act synergistically in vivo. Offspring carrying the CD2-myc transgene and the homozygous p53 null mutation (p53-/-/CD2-myc) were viable but developed thymic lymphomas with dramatically increased frequency and reduced latency compared to both parental groups. The tumour phenotype was similar to that previously recorded for CD2-myc mice (predominantly CD3+, CD4+8+) but tumour clonal complexity and metastasis was significantly greater in the p53-/-/CD2-myc mice. In contrast, no significant increase in tumour incidence was seen in p53+/-/CD2-myc vs p53+/+/CD2-myc mice over a 6 month observation period. However, the loss of wild type p53 in a proportion of tumour cells in p53+/-/CD2-myc lymphomas suggests that wild type allele loss can occur as a late progression step rather than an initiating step in these tumours. We suggest that p53 loss of function may collaborate with the CD2-myc transgene at more than one stage in thymic lymphoma development.

Item Type: Articles
Status: Published
Refereed: Yes
Glasgow Author(s) Enlighten ID: Neil, Professor James and Stewart, Dr Monica and Terry, Mrs Anne and Onions, Professor David and Cameron, Professor Ewan and Blyth, Professor Karen
Authors: Blyth, K., Terry, A., O'Hara, M., Baxter, E.W., Campbell, M., Stewart, M., Donehower, L.A., Onions, D.E., Neil, J.C., and Cameron, E.R.
College/School: College of Medical Veterinary and Life Sciences > School of Cancer SciencesCollege of Medical Veterinary and Life Sciences > School of Infection & ImmunityCollege of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name: Oncogene
Publisher: Stockton Press
ISSN: 0950-9232
ISSN (Online): 1476-5594

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details

ID Code: 123956
Depositing User: Mrs Louise Annan-Moat
Datestamp: 05 Sep 2016 10:45
Last Modified: 02 May 2025 10:41
Date of acceptance: 14 February 1995
Date of first online publication: 4 May 1995